Consolidated Amendment #F to H.4000

Consolidated Amendment "F" to H4000

Public Health

Fiscal Note: $9,981,695

Amendment 135 has been re-categorized to Health and Human Services

Amendment 1027 has been re-categorized to Public Safety

Amendments from Public Health: 14, 32, 51, 82, 83, 85, 91, 100, 104, 136, 171, 209, 213, 215, 242, 261, 269, 281, 283, 342, 351, 379, 385, 401, 410, 415, 416, 423, 440, 473, 476, 484, 548, 562, 567, 571, 574, 579, 612, 618, 631, 669, 683, 688, 714, 718, 736, 741, 749, 762, 783, 787, 797, 826, 828, 841, 850, 851, 853, 855, 861, 862, 878, 886, 893, 916, 928, 933, 940, 964, 966, 984, 992, 1000, 1002, 1005, 1030, 1037, 1044, 1049, 1053, 1059, 1072, 1077, 1086, 1090

Mr. Dempsey of Haverhill and others move to amend H.4000 in section 2, in item 4510-0110, by inserting after the words “254c(f)(1)” the following words:- ; provided further, that not less than $250,000 shall be expended for the operation and implementation of the South Boston Community Health Center and its Youth Ambassador Program and South Boston Leadership Initiative; provided further, that not less than $50,000 be expended to form the Mattapan Integrative Care Partnership Pilot program among the Mattapan Community Health Center, Mattahunt Community Center, Mattahunt Elementary School, and the Wheelock College Social Work Department to establish a behavioral health practice at the Mattapan Community Health Center and support a full time licensed social worker to bring mental health care to the community’s youth and to improve the coordination of care; and move to further amend said item by striking out the figure “$1,287,593” and inserting in place thereof the following figure:- $1,587,593;

And further move to amend said section 2, in item 4510-0600, by inserting after the words “October 3, 2014” the following words:- ; provided further, that not less than $50,000 shall be expended for a city wide restaurant and food safety education program in the city of Marlborough; and further move to amend said item by striking out the figure “$4,591,980” and inserting in place thereof the following figure:- $4,641,980;

And further move to amend said section 2, in item 4510-0712, by inserting after the words “licensure and recertification” the following words:- ; provided further, that not less than $150,000 shall be expended for the hiring of 2 positions, 1 full time data registrar and 1 part-time data analyst in the office of emergency medical services; and further move to amend said item by striking out the figure “$2,481,081” and inserting in place thereof the following figure:- $2,631,081;

And further move to amend said section 2, in item 4510-0810, by striking out the figure “$3,554,426” and inserting in place thereof the following figure:- $3,754,426;

And further move to amend said section 2, in item 4512-0103, by inserting after the words “HIV/AIDS and associated conditions” the following words:- ; provided further, that not less than $120,000 shall be expended to conduct a hepatitis C pilot program at the North Shore Health Project; and further move to amend said item by striking out the figure “$32,102,505” and inserting in place thereof the following figure:- 32,222,505;

And further move to amend said section 2, by striking out item 4512-0200 and inserting in place thereof the following item:-

4512-0200 For the division of substance abuse services, including a program to reimburse driver alcohol education programs for services provided for court adjudicated indigent clients; provided, that programs in substantial regulatory and contractual compliance shall receive the same percentage level of funding in fiscal year 2015 as received in fiscal year 2014; provided further, that not less than $300,000 shall be expended for integrated treatment and stabilization services for individuals and families with co-occurring substance abuse and mental health disorders; provided further, that not less than $100,000 shall be expended for the New Beginnings program that targets youth at risk and in recovery in collaboration with school districts; provided further, that not less than $150,000 shall be expended for Self-Esteem Boston’s direct services programs for women in the Metro-Boston region and provider training programs; provided further, that not less than $50,000 shall be expended for the Drug Story Theatre of the South Shore pilot program for substance abuse prevention and education; provided further, that not less than $15,000 shall be expended for a city wide drug and alcohol awareness campaign for the city of Marlborough; provided further, that not less than $100,000 shall be expended to the Berkshire County youth development project for youth intervention services; provided further, that not more than $100,000 shall be expended for Project RIGHT’s substance abuse and trauma prevention initiative in the Grove Hall area of Boston; provided further, that not less than $50,000 shall be expended for the addiction services special commission established in section 101I of this act; provided further, that not less than $250,000 shall be expended for a pilot program for young adults aged 17 to 25 to address substance abuse issues for this age group; provided further, that not less than $500,000 shall be expended for a voluntary training and accreditation program for owners and operators of alcohol and drug free housing; and provided further, that not less than $1,300,000 shall be expended to support and strengthen public access to substance abuse services in the commonwealth, including, but not limited to, the following: (i) expanding the number and type of the facilities to provide treatment, (ii) expanding central intake capacity, (iii) placing addiction specialists in selected courts, and (iv) expanding detoxification services in the public system by no less than 32 public detoxification beds and 32 clinical stabilization services beds……………………$90,267,333;

And further move to amend said section 2, in item 4512-0204, by striking out the figure “$815,000” and inserting in place thereof the following figure:- $1,000,000;

And further move to amend said section 2 by striking out item 4512-0500 and inserting in place thereof the following item:-

4512-0500 For dental health services; provided, that funds shall be expended to maintain a program of dental services for the developmentally disabled; provided further, that not less than $300,000 shall be expended for the Forsyth Institute’s Center for Children’s Oral Health to expand its ForsythKids elementary school program, expand its Forsyth Teens smoking cessation program, and measure each program’s impact on school performance; and provided further, that not less than $1,459,525 shall be expended for the commonwealth’s comprehensive dental program for adults with developmental disabilities with no less than $100,000 for the promotion of services to all dental providers in the commonwealth and increase after-hour, weekend, and holiday coverage with on-call response and if necessary actual clinical evaluation…………..$2,328,397;

And further move to amend said section 2, in item 4513-1000, by striking out the figure “$4,816,697” and inserting in place thereof the following figure:- $5,016,697;

And further move to amend said section 2, in item 4513-1020, by striking out the figure “$26,420,583” and inserting in place thereof the following figure:- $27,420,583;

And further move to amend said section 2, in item 4513-1026, by striking out the figure “$3,863,305” and inserting in place thereof the following figure:- $4,000,000;

And further move to amend said section 2, by inserting after item 4513-1026 the following item:-

4513-1098 For the provision of statewide support services for survivors of homicide victims, including outreach services, burial assistance, grief counseling and other support services; provided, that funds shall be expended as grants in the aggregate amount of $125,000 to the Louis D. Brown Peace Institute, a community based support organization dedicated to serving families and communities impacted by violence……………….$125,000;

And further move to amend said section 2, in item 4513-1111, by inserting after the word “prevention” the following words:- including, but not limited to, the following programs: breast cancer prevention; diabetes screening and outreach; ovarian cancer screening; a statewide STOP stroke program and ongoing stroke prevention and education; hepatitis C prevention and management; multiple sclerosis screening, information, education and treatment programs and the multiple sclerosis home living navigating key services program administered by the Central New England Chapter of the National Multiple Sclerosis Society; colorectal cancer prevention; prostate cancer screening, education and treatment with a particular focus on African American males; osteoporosis education; and maintenance of the statewide lupus database; provided, that funds may be expended for the operation of the Betsy Lehman Center for Patient Safety and Medical Error Reduction; provided further, that not less than $50,000 shall be expended for education and support of patients diagnosed with PKU or related disorders and their families through a grant to NECPAD; provided further, that notwithstanding any general or special law to the contrary, $100,000 shall be appropriated to the University of Massachusetts – Dartmouth to be expended for operation of the Cranberry Health Research Center at the University of Massachusetts – Dartmouth; provided further, that not less than $50,000 shall be expended for the Haitian American Public Health Initiative to provide vital healthcare and education services to families and children in the Haitian community in the city of Boston and town of Milton; and further move to amend said item by striking out the figure “$3,242,377” and inserting in place thereof the following figure:- $3,442,377;

And further move to amend said section 2, in item 4590-0250, by inserting after the words “secondary education” the following words:- ; provided further, that the department of public health shall expend not less than $100,000 on the Massachusetts Model of Community Coalitions; and further move to amend said item by striking out the figure “$12,177,055” and inserting in place thereof the following figure:- $12,277,055;

And further move to amend said section 2, in item 4590-0915, by inserting after the words “section 2B” the following words:- ; provided further, that the Massachusetts hospital school shall maintain not less than 120 beds for clients in its inpatient setting to the extent feasible within the appropriation; and further move to amend said item by striking out the figure “$144,265,923” and inserting in place thereof the following figure:- $148,265,923;

And further move to amend said section 2, in item 4590-0925, by inserting after the word “standardization” the following words:- ; provided further, that said research foundation may also expend funds from this item for a prostate cancer public education and awareness program, focusing in particular on men with African-American heritage, family history of the disease, and other men of high risk;

And further move to amend said section 2, in item 4590-1506, by striking out the figure “$1,000,000” and inserting in place thereof the following figure:- $1,150,000;

And further move to amend said section 2, in item 4590-1507, by inserting after the words “matching funds from those organizations” the following words:- ; provided further, that not less than $50,000 shall be expended for youth programs at Dennison Memorial Community Center in New Bedford; provided further, that the department of public health shall award not less than $1,000,000 to the Massachusetts Alliance of Boys & Girls Clubs, which shall be distributed equally between said recipient’s member organizations; provided further, that the department shall award not less than $900,000 to the Alliance of Massachusetts YMCAs, which shall be distributed between the recipient’s member organizations; provided further, that not less than $50,000 shall be expended for the Center for Teen Empowerment, Inc.; provided further, that not less than $50,000 shall be expended for Crossroads for Kids for expansion of their summer and year round out of school program serving at –risk youth; and further move to amend said item by striking out the figure “$1,800,000” and inserting in place thereof the following figure:- $3,850,000;

And further move to amend the bill by inserting after section 11 the following sections:-

SECTION 11F. Section 13 of chapter 17 of the General Laws, as appearing in the 2012 Official Edition, is hereby amended by inserting after the third paragraph the following 2 paragraphs:-

The commission shall also prepare a drug formulary of abuse-deterrent interchangeable opioid drug products, which shall be adopted by regulations of the department, and which shall list commercially available abuse-deterrent products that serve as equivalent alternatives to non- abuse-deterrent opioid products. Said formulary shall include formulations of opioid drugs of schedules II through V that are pharmaceutically and therapeutically equivalent and interchangeable, and that also incorporate abuse-deterrent technology satisfying at least 2 of the following criteria:

(i) Physical or chemical barriers that can prevent chewing, crushing, cutting, grating, grinding, melting or other physical manipulations that enable abuse, or resist extraction of the opioid by common solvents such as water, alcohol or other organic solvents;

(ii) Agonist/antagonist combinations that interfere with, reduce or defeat the euphoria associated with abuse;

(iii) Aversion qualities that produce an unpleasant effect if the dosage form is manipulated or altered, or a higher dosage than directed is used;

(iv) Delivery systems that, pursuant to United States Food and Drug Administration guidance, offer resistance to abuse;

(v) Product techniques that limit opioid activity until transformed in the gastrointestinal tract; or

(vi) A combination of 2 or more of the above methods to deter abuse, or

(vii) Other techniques as may be identified or recommended by the Food and Drug Administration that offer significant abuse deterrence.

In preparing a formulary of abuse-deterrent opioid drug products that are interchangeable with non-abuse-deterrent opioid drug products, the commission shall consider information contained in an abuse-deterrent opioid drug product’s labeling approved by the United States Food and Drug Administration, and other regulatory and guidance documents distributed by said administration. A determination of interchangeability between 2 drug products shall not require that both products incorporate the same methods of abuse-deterrence, but that the products must have at least the same degree of FDA-approved abuse-deterrent labeling claims. Inclusion of a drug on this formulary shall not be construed to authorize labeling or marketing claims of abuse deterrence potential, unless such claims are authorized by the Food and Drug Administration.

SECTION 11G. Said section 13 of said chapter 17, as so appearing, is hereby further amended by striking out, in lines 29, 34, and 39 the word “formulary” and inserting in place thereof, in each instance, the word:- formularies;

And further move to amend the bill by inserting after section 14 the following section:-

SECTION 14A. Chapter 17 of the General Laws is hereby amended by inserting after section 19 the following section:-

Section 20. (a) There shall be a Massachusetts Interagency Council on Substance Abuse and Prevention. The interagency council shall: (i) support the efforts of the department of public health to supervise, coordinate and establish standards for the operation of substance use prevention and treatment services; (ii) oversee implementation of initiatives and programs that effectively direct the existing resources and minimize the impact of substance abuse; (iii) develop and recommend formal policies and procedures for the coordination and efficient utilization of programs and resources across state agencies and secretariats; (iv) develop an annual report and submit to the governor, on or before November 30 of each year, all activities of the council and recommend further efforts and resource needs; and (v) review the role and functions of the advisory council on alcoholism, and the drug rehabilitation advisory board pursuant to chapter 118E, and recommend changes as necessary.

(b) The interagency council shall consist of the following members or their designees: the secretary of health and human services, who shall serve as chair; the secretary of public safety; the secretary of elder affairs; the secretary of veterans affairs; the commissioner of education; the commissioner of correction; the chair of the parole board; the commissioner of probation; the commissioner of public health; the commissioner of youth services; the commissioner of mental health; the commissioner of developmental services; the commissioner of the Massachusetts rehabilitation commission; the commissioner of transitional assistance; the commissioner of children and families; the commissioner of the center for health information and analysis; the commissioner for the deaf and hard of hearing; the commissioner for early education and care; the assistant commissioner of public health for substance abuse services; the director of the office of Medicaid; a representative of the juvenile court; a representative of the superior court; a representative of the district court; a representative of the governor's office; 1 private citizen who is recovering from substance abuse problems, appointed by the governor; 1 member appointed by the president of the senate; 1 member appointed by the speaker of the house; 1 member appointed by the senate minority leader; 1 member appointed by the house minority leader; and other appropriate representatives as determined by the governor. The council may appoint an executive director to perform administrative functions and advocate on behalf of the council. All members shall serve without compensation in an advisory capacity and at the pleasure of the governor.

(c) The interagency council shall meet at least 4 times annually and shall establish task groups, meetings, forums and any other activity deemed necessary to carry out its mandate.

(d) The interagency council will establish an executive committee composed of a minimum of 11 members that will meet on a bi-monthly basis to provide guidance on the recommendations of the council. At minimum, the executive committee will be comprised of the following members or their designees: the secretary of health and human services, the secretary of public safety; the commissioner of public health; the commissioner of children and families; the commissioner of correction; the commissioner of mental health; the commissioner of youth services; the director of the office of Medicaid; the assistant commissioner of public health for substance abuse services; and at least 2 additional members from the council.

(e) All affected agencies, departments and boards of the commonwealth shall fully cooperate with the interagency council. The council may call and rely upon the expertise and services of individuals and entities outside of its membership for research, advice, support or other functions necessary and appropriate to further accomplish its mission.

And further moves to amend the bill by inserting after section 39 the following section:-

SECTION 39A. Section 18 of Chapter 94C of the General Laws, as appearing in the 2012 Official Edition, is hereby amended by inserting after subsection (e) the following subsection:- (f) A prescription shall not be issued or filled for any opioid drug product or substance contained in schedule II to IV that is formulated as a non-abuse-deterrent opioid drug, as defined in section 12D of chapter 112, unless the drug formulary commission has determined, pursuant to section 13 of chapter 17, that no abuse-deterrent interchangeable opioid drug product is available as a substitute for the indicated product or substance.

And further moves to amend the bill by inserting after section 44 the following section:-

SECTION 44A. Chapter 111 of the General Laws is hereby amended by inserting after section 4M the following section:-

Section 4M 1/2. (a) As used in this section the following words shall, unless the context clearly requires otherwise, have the following meanings:-

“Hepatitis C screening test”, any FDA-approved laboratory screening test, FDA-approved rapid point-of-care test, or other FDA-approved tests that detect the presence of hepatitis C antibodies in the blood.

“Hepatitis C diagnostic test", a laboratory test that detects the presence of hepatitis C virus in the blood and provides confirmation of whether the person whose blood is being tested has a hepatitis C virus infection.

(b) Every individual born between the years of 1945 and 1965 who receives health care services from a primary care provider shall be offered a hepatitis C screening test or Hepatitis C diagnostic test unless the provider believes that: (i) the individual is being treated for a life threatening emergency; or (ii) the individual has previously been offered or has received a hepatitis screening test; or (iii) the individual lacks capacity to consent to a hepatitis C screening test.

And further move to amend the bill by inserting after section 45 the following section:-

SECTION 45B. Chapter 111 of the General Laws is hereby amended by inserting after section 78A the following section:

Section 78B. (a) The commissioner, the commissioner of the department of mental health, the director of Medicaid, the executive director of the group insurance commission and the executive director of the health policy commission, in consultation with representatives of hospitals, long term care facilities, outpatient facilities, primary care providers, community health centers, community mental health centers, consumer representatives, patients with chronic conditions and any other representatives deemed necessary, shall, subject to appropriation, develop a plan: (1) to reduce the incidence of chronic disease, including, but not limited to, chronic cardiovascular disease, cancer, stroke, chronic lung disease, chronic obstructive pulmonary disease, diabetes, arthritis, chronic metabolic disease and mental illness; (2) to improve chronic care coordination in the commonwealth; and (3) for each type of health care facility and coordinated care organization including integrated care organizations, accountable care organizations and patient-centered medical homes to reduce the incidence and effects of chronic disease.

(b) At least 1 year after completion of the plan required in subsection (a), the commissioners and directors shall submit a bi-annual report to the governor, the chairs of the joint committee on public health, the chairs of the joint committee on mental health, and the chairs of the joint committee on health care financing concerning chronic disease and implementation of said plan. The commissioners and directors shall make the report available on the departments’ web sites not later than 30 days after submitting the report. The report shall include, but is not limited to: (1) a description of the chronic diseases that are most likely to cause a person's death or disability, the approximate number of persons affected by each chronic disease and an assessment of the financial effect of each disease on the commonwealth and on hospitals and other health care facilities; (2) a description and assessment of programs and actions that have been implemented by the departments or hospitals and other health care facilities to improve chronic care coordination and prevent disease; (3) the source and amount of funding received by the departments to treat persons with multiple chronic conditions and to treat or reduce the most prevalent chronic diseases in the state; (4) a description of chronic care coordination between the departments and hospitals and other health care facilities and among health care facilities to prevent and treat chronic disease; (5) detailed recommendations concerning actions to be taken by integrated care organizations, accountable care organizations, patient-centered medical homes, hospitals and other health care facilities to reduce the effects of the most prevalent chronic diseases, including recommendations concerning: (i) ways to reduce hospital readmission rates, (ii) transitional care plans, (iii) drug therapy monitoring, (iv) collaborative drug therapy management, (v) comprehensive medication management as defined in section 3503(c) of the Affordable Care Act, section 935 of 42 U.S.C. 299b–35(c), to help patients with multiple chronic conditions achieve clinical and patient goals of therapy and improve clinical outcomes, (vi) adoption of quality standards that are publicly reported evidence-based measures endorsed through a multi-stakeholder process such as the National Quality Forum and (vii) patient self-management training; (6) identification of anticipated results from a hospital or other health care facility's implementation of the recommendations described in clause (5) of this subsection; (7) identification of goals for coordinating care and reducing the incidence of persons having multiple chronic conditions; and (8) an estimate of costs and other resources necessary to implement the recommendations described in clause (5) of this subsection.

And further moves to amend the bill by inserting after section 53 the following sections:-

SECTION 53A. Section 12D of Chapter 112 of the General Laws, as appearing in the 2012 Official Edition, is hereby amended by inserting after the definition of “Practitioner” the following 2 definitions:-

“Non-abuse-deterrent opioid drug product”, any opioid drug product that is approved for medical use but that does not meet the requirements for listing as a abuse-deterrent interchangeable opioid drug product.

“Abuse-deterrent interchangeable opioid drug product”, an opioid drug that is rated by the U.S. Food and Drug Administration as pharmaceutically and therapeutically equivalent to the prescribed product or substance, and that also incorporates abuse-deterrent technology and has been identified as such by the drug formulary commission in accordance with section 13 of chapter 17.

SECTION 53B. Said section 12D is hereby further amended by inserting after the word “practitioner.”, in line 32, the following paragraph:-

Notwithstanding the substitution requirements of this section, or any brand name or “no substitution” indication by the practitioner, the pharmacist shall not, in any case, dispense an opioid drug of schedule II to schedule IV that is formulated as a non-abuse-deterrent opioid drug product, unless the drug formulary commission has determined that no abuse-deterrent interchangeable opioid drug product is available as a substitute for the indicated product or substance.

And further moves to amend the bill by inserting after section 62 the following section:-

SECTION 62A. Chapter 176O of the General Laws, as appearing in the 2012 Official Edition, is hereby amended by inserting after Section 16 the following section:

Section 16A. A carrier may not exclude or deny reimbursement for abuse-deterrent opioid drug products dispensed in accordance with section 12D of chapter 112 solely due to the cost of said abuse-deterrent products; provided, however, that this section shall not be construed to prohibit a carrier from applying prior authorization requirements and utilization reviews for opioid drug products when such measures, and any service denials made pursuant thereto, do not require treatment failures of non-abuse deterrent products in order access abuse-deterrent products.

And further move to amend the bill in section 78 by striking out, in lines 823 and 824, the words “marketing and prescribing of such controlled substances” and inserting in place thereof the following words:- distribution of such controlled substances.; and further move to amend said section by inserting the following paragraph:-

As used in this section the following words shall, unless the context clearly requires otherwise, have the following meanings “Abuse-deterrent formulation”, an opioid drug used to treat pain that is considered to have abuse deterrent properties if the FDA determines there is sufficient evidence to support abuse deterrent claims based on published FDA Guidance. “Non-abuse-deterrent formulation”, an opioid drug used to treat pain that is not considered an abuse-deterrent formulation.

No health insurance policy issued or renewed in the state that provides coverage for prescription drugs shall require, as a condition of coverage, use of a non-abuse-deterrent formulation prior to use of a formulary drug that is an abuse-deterrent formulation, for the treatment of pain.

And further moves to amend the bill by inserting after section 101 the following sections:-

SECTION 101I. There is hereby established a special commission for the purposes of investigating and studying the development of criteria for mandated treatment or monitoring of nonviolent offenders with substance addictions and to expand effective, evidence based addiction treatment programs for nonviolent substance addicted offenders. The commission shall consist of the court administrator or a designee, who shall serve as co-chair; the director of the bureau of substance abuse services or a designee, who shall serve as co-chair; the chief justice of the trial court or a designee; the attorney general or a designee; the secretary of public safety and security or a designee; the commissioner of the department of correction or a designee; the chair of the parole board or a designee; the commissioner of the department of probation or a designee; the chief counsel of the committee for public counsel services or a designee; the commissioner of the department of mental health or a designee; the secretary of the department of veterans’ services or a designee; 2 members of the senate, 1 of whom shall be appointed by the senate president and 1 of whom shall be appointed by the senate minority leader; 2 members of the house of representatives, 1 of whom shall be appointed by the speaker of the house and 1 of whom shall be appointed by the house minority leader; the president of the Massachusetts District Attorneys Association or a designee; the president of the Massachusetts Bar Association or a designee; and 2 members appointed by the governor, 1 of whom shall be a substance addiction treatment expert and 1 of whom shall be a mental health treatment expert.

Such investigation and study shall include, but not be limited to: (a) an evaluation of the application and effectiveness of “Standards on Substance Abuse,” approved by the justices of the supreme judicial court on April 28, 1998, and recommendations to improve and ensure the consistent application of the standards in the courts; (b) an evaluation and recommendations for improvement of specialty courts that address substance addictions, including current eligibility requirements or practices, availability of such courts and use of best practices in establishing quality of services; (c) the optimum number and estimated expansion costs associated with the drug courts necessary to meet the needs of the total annual number of nonviolent substance addicted offenders; (d) an evaluation of the number and type of nonviolent offenses committed by substance addicted defendants adjudicated in the commonwealth; (e) the development of a definition of nonviolent substance addicted offender; (f) an examination of best practices relative to specialty courts that deal with substance addicted offenders, both within the commonwealth and in other states; (g) an assessment of the quantity, quality and availability of effective, evidence based addiction treatment programs in the commonwealth; and (h) an assessment of the cost of expanding addiction treatment resources to meet the needs of the total annual number of nonviolent substance addicted offenders.

The commission shall submit its report and findings, along with any draft of legislation, to the house and senate committees on ways and means, the joint committee on the judiciary, the joint committee on public health, the joint committee on mental health and substance abuse, and the clerks of the house of representatives and the senate on or before December 31, 2014.

SECTION 101J. There is hereby established a special commission to study and establish recommendations to promote the safe and appropriate use of opiate medications by patients that may be employed by state agencies and the private sector companies who provide insurance coverage. The commission shall consist of the secretary of administration and finance, or a designee, who shall serve as chair; the commissioner of public health, or a designee; the commissioner of insurance, or a designee; the director of the office of Medicaid, or a designee; the executive director of the group insurance commission, or a designee; and 3 members appointed by the Governor, 1 of whom shall be a representative from the Massachusetts Hospital Association, 1 of whom shall be a representative from the Massachusetts Medical Society and 1 of whom shall be a representative from the Massachusetts Association of Health Plans. The commission shall examine best practices currently used in the public and private sector to ensure patient safety through prescription monitoring of opiates including, but not limited to, prior authorization requirements, restrictions on prescription refills, determination of excessive use, addiction assessments, the need for substance abuse treatment plans and data collection practices. The commission shall file its report and recommendations with the clerks of the house of representatives and senate, the chairs of the joint committee on health care financing and the chairs of the house and senate committees on ways and means on or before January 15, 2015.